AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net selling: insiders sold $19.6M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$19.6M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 5- Open
- $77.67
- 52-wk high
- $94.00
- High
- $78.68
- 52-wk low
- $56.94
- Low
- $76.93
- Prev close
- $76.35
- Mkt cap
- $3.97B
- P/E
- 21.6x
- Volume
- 376.7K
- Fwd P/E
- 9.9x
- Beta
- 0.83
- Div yield
- 2.39%
- P/S
- 1.1x
- P/B
- 2.5x
- Profit margin
- +5.2%
- Op margin
- +14.3%
- ROE
- +13.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CBT filings
Are insiders buying or selling Cabot Corporation (CBT) stock?
Net selling: insiders sold $19.6M and bought $0 of CBT stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. The largest was Keohane, Sean D (President and CEO), who sold $19.6M. The latest filing was on Aug 31, 2026.
Which members of Congress have traded CBT recently?
None. No member of Congress disclosed a CBT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CBT smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- MI
Millennium
$43.7M
added
What insiders are doing
Sells (3)
- KS
Keohane Sean D
$11.5M
sold
- KS
Keohane Sean D
$238K
sold
- KS
Keohane Sean D
$7.9M
sold
How top traders are positioned
No tracked top-trader positions in CBT right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings landed in line with what analysts expected.
Last report
Aug 3, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.66 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 3, 2026 | $1.67 / $1.66Alpha Vantage | +0.60% in line | Unavailable | Unavailable |
| Mar 31, 2026 | May 5, 2026 | $1.61 / $1.47Alpha Vantage | +9.52% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 3, 2026 | $1.53 / $1.38Alpha Vantage | +10.87% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 3, 2025 | $1.70 / $1.68Alpha Vantage | +1.19% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 4, 2025 | $1.90 / $1.83Alpha Vantage | +3.83% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 5, 2025 | $1.90 / $1.86Alpha Vantage | +2.15% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 3, 2025 | $1.76 / $1.77Alpha Vantage | -0.56% in line | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 4, 2024 | $1.80 / $1.79Alpha Vantage | +0.56% in line | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 2, 2026, in 28 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $899.0M | $849.0M | $904.0M | $982.0M |
| Cost of what it sold | $679.0M | $638.0M | $687.0M | $798.0M |
| Gross profit | $220.0M | $211.0M | $217.0M | $184.0M |
| What it spent | ||||
| Research and development | $15.0M | $13.0M | $14.0M | $13.0M |
| Sales and admin | $68.0M | $69.0M | $67.0M | $73.0M |
| Other operating costs | — | — | -$1.0M | — |
| Total operating expenses | $83.0M | $82.0M | $80.0M | $86.0M |
| What was left | ||||
| Operating profit | $137.0M | $129.0M | $137.0M | $98.0M |
| Interest on debt | $20.0M | $18.0M | $19.0M | $18.0M |
| Profit before tax | $117.0M | $119.0M | $122.0M | $60.0M |
| Tax | $63.0M | $37.0M | $44.0M | $46.0M |
| Net profit | $43.0M | $73.0M | $68.0M | $6.0M |
| EBITDA | $175.0M | $177.0M | $190.0M | $148.0M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Cabot Corporation (NYSE:CBT) Stock Rated "Hold" by Sell-Side Analysts
NeutralOct 2A cash-settled stock award gives Cabot (CBT) director Raffiq Nathoo 360.8113 units.
NeutralOct 1A retirement-plan grant adds 346.259 stock-linked units for Cabot (CBT)'s CEO.
NeutralOct 1Cabot (CBT) counsel acquires 44.8795 stock-linked units under its supplemental 401(k) plan.
NeutralOct 1Cabot Corp CEO Sean D. Keohane Acquires 346 Phantom Stock Units via Supplemental 401(k) Plan
Leans bullishOct 1Cabot Corp SVP Karen Kalita Acquires Phantom Stock Units via Supplemental 401(k) Plan
NeutralOct 1CBT.GP Bond Profile: Coupon and Redemption
NeutralOct 1CBT4847793 Bond Profile: Coupon and Redemption
NeutralSep 28
Macro
11 macro signals shaping CBT right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results